India’s largest equity bourse, NSE, will invest Rs 380 crore to build a new 11-storey multi-speciality cancer treatment block and India’s largest bone marrow transplant centre at TMH-run ACTREC in Navi Mumbai. Expected by July 2027, this CSR-funded facility aims to handle 1.3 lakh outpatient visits annually and over 600 BMTs, significantly addressing critical healthcare gaps for cancer patients.